(Q57618665)
Statements
Elevated end-of-treatment serum INSL3 is associated with failure to completely suppress spermatogenesis in men receiving male hormonal contraception (English)
Stephanie T Page
Bradley D Anawalt
Andrea D Coviello
Alvin M Matsumoto
William J Bremner
21 February 2007